We are thrilled to announce that the European Conference on Rare Diseases (ECRD) 2024 is now accepting poster abstract submissions. This conference, organised by EURORDIS and co-organised by Orphanet, is an excellent opportunity for patient groups, academics, healthcare professionals, and others involved in rare disease research or public health projects to contribute and share their insights.
Submission Guidelines
Submissions should be in English and limited to 300 words. Participants can be co-authors of multiple poster abstracts, but only the representing author of one. Additionally, representing authors of accepted posters must register to attend ECRD 2024, either onsite or online, to ensure their posters are displayed. We also accept posters that have been presented at other events. The deadline to submit is 4 March 2024.
Accepted Posters
All accepted posters will be available on the ECRD 2024 virtual platform, facilitating interaction, Q&A sessions, and networking. The top three posters will receive an award, and selected authors will have the chance to present their work live during the conference. Furthermore, authors of the top 40 posters will be invited to submit their abstracts for publication in a special edition of the Orphanet Journal of Rare Diseases (OJRD).
Selection Process
The ECRD 2024 Poster Committee will review submissions in March, and notifications will be sent by the month's end. Posters will be evaluated based on relevance to rare diseases, quality of content, originality, and practical application. It's important to note that while we encourage scientific contributions, posters must align with the conference's focus and themes. Case reports will not be accepted.
Disqualification Criteria
Submissions promoting commercial products, not adhering to the guidelines, submitted after the deadline, or through incorrect channels will be disqualified.
This is your chance to be part of a vital conference in the rare diseases community. Don't miss the opportunity to share your work, connect with peers, and contribute to advancing knowledge and practices in this field.
For more information or any queries, please visit the ECRD website or contact the ECRD support team.
